TokenPost topic
1 TokenPost story is tagged ESMO Congress. The newest appear first.
The update covers data through June 22 from an ongoing Phase 1/2 study. Dose-optimization results are intended to help select a dose and schedule for a planned Phase 3 desmoid tumor trial.
Oct 19, 2026, 6:50 PM EDT ยท Business